Texas 2017 - 85th Regular

Texas Senate Bill SB1342 Compare Versions

Only one version of the bill is available at this time.
OldNewDifferences
11 85R9724 MCK-D
22 By: Garcia S.B. No. 1342
33
44
55 A BILL TO BE ENTITLED
66 AN ACT
77 relating to prohibited nonconsensual genital surgery on certain
88 minors with intersex traits.
99 BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
1010 SECTION 1. Sections 266.001 through 266.012, Family Code,
1111 are designated as Subchapter A, Chapter 266, Family Code, and a
1212 heading is added to Subchapter A to read as follows:
1313 SUBCHAPTER A. GENERAL PROVISIONS; EDUCATIONAL SERVICES; MEDICAL
1414 CARE
1515 SECTION 2. Chapter 266, Family Code, is amended by adding
1616 Subchapter B to read as follows:
1717 SUBCHAPTER B. MEDICAL PROCEDURES AND TREATMENTS RELATED TO
1818 INTERSEX TRAITS
1919 Sec. 266.051. DEFINITIONS. In this subchapter:
2020 (1) "Intersex child" means an individual who is
2121 younger than 18 years of age and either:
2222 (A) has inborn chromosomal, gonadal, genital, or
2323 endocrine characteristics, or a combination of those
2424 characteristics, that are not suited to the typical definition of
2525 male or female or are atypical for the sex assigned; or
2626 (B) is considered by a medical professional to
2727 have inborn chromosomal, gonadal, genital, or endocrine
2828 characteristics that are ambiguous or atypical for the sex
2929 assigned.
3030 (2) "Medical procedure or treatment related to an
3131 intersex trait" includes genital surgery, gonadal surgery, or
3232 hormonal treatment to treat or modify an intersex trait.
3333 (3) "Medically necessary" means a medical procedure or
3434 treatment immediately necessary to treat an injury, illness,
3535 disease, or condition affecting the intersex child's health that if
3636 delayed would adversely affect the intersex child's physical
3737 health.
3838 Sec. 266.052. REQUIREMENTS FOR CERTAIN MEDICAL PROCEDURES
3939 OR TREATMENTS. A physician may not perform a medical procedure or
4040 treatment related to an intersex trait on a foster child younger
4141 than 12 years of age unless:
4242 (1) the procedure or treatment is medically necessary
4343 for the physical health of the child and the department consents to
4444 the procedure or treatment; or
4545 (2) the procedure or treatment is not medically
4646 necessary for the physical health of the child and a court
4747 authorizes the procedure or treatment as provided under this
4848 subchapter.
4949 Sec. 266.053. COURT APPROVAL OF CERTAIN MEDICAL PROCEDURES
5050 OR TREATMENTS. (a) If the department or an intersex child's
5151 physician wants the child to undergo a medical procedure or
5252 treatment related to an intersex trait that is not medically
5353 necessary for the physical health of the child, the department or
5454 physician may file a petition with the court having continuing
5555 jurisdiction over the intersex child seeking court approval of the
5656 procedure or treatment.
5757 (b) The court shall hold a hearing to determine whether the
5858 proposed medical procedure or treatment related to an intersex
5959 trait is in the child's best interest.
6060 (c) The child must be represented by an attorney at the
6161 hearing. The attorney for the child must:
6262 (1) possess adequate knowledge of intersex traits, the
6363 intersex population, and the range of medical procedures or
6464 treatments that may be pursued in connection with the child's
6565 intersex trait, including the option to delay any procedure or
6666 treatment;
6767 (2) communicate with the child, to the extent possible
6868 given the child's age, regarding:
6969 (A) the nature of the proposed medical procedure
7070 or treatment;
7171 (B) the extent to which the proposed medical
7272 procedure or treatment is irreversible; and
7373 (C) the projected outcome of, the possible risks
7474 associated with, and the alternatives, including delay, to the
7575 proposed medical procedure or treatment;
7676 (3) interview the child, to the extent possible given
7777 the child's age, to determine the child's wishes regarding the
7878 pursuit or delay of any proposed medical procedure or treatment;
7979 (4) assist the child, to the extent possible given the
8080 child's age, in assessing the child's desires related to the child's
8181 medical care and in communicating the child's desires to the court;
8282 and
8383 (5) for a child younger than 12 years of age, argue
8484 against a proposed medical procedure or treatment that is not
8585 medically necessary for the physical health of the child.
8686 (d) Any party to the suit may submit to the court a report or
8787 introduce evidence from a qualified expert on:
8888 (1) intersex traits and the intersex population in
8989 general;
9090 (2) the child's specific intersex traits;
9191 (3) the range of medical procedures and treatments
9292 that may be pursued in connection with the child's intersex traits,
9393 including delay;
9494 (4) the specific medical procedure or treatment
9595 proposed for the child, including the risks and anticipated
9696 benefits associated with the procedure or treatment and the
9797 possibility that the child's ultimate gender identity may differ
9898 from the sex assigned;
9999 (5) the extent to which the medical procedure or
100100 treatment:
101101 (A) is irreversible; and
102102 (B) may safely be delayed until the child is of an
103103 age to participate in the decision-making process;
104104 (6) the physician's responsibilities to obtain
105105 informed consent from the child and the child's parent or guardian
106106 and whether those responsibilities have been adequately
107107 discharged; and
108108 (7) the public statements of intersex individuals or
109109 patient advocates regarding Subdivisions (1)-(6).
110110 (e) Following the hearing, the court shall determine
111111 whether the proposed medical procedure or treatment related to an
112112 intersex trait is in the child's best interest and render an order
113113 with specific findings on:
114114 (1) whether clear and convincing evidence establishes
115115 that the short-term or long-term physical benefits of the proposed
116116 medical procedure or treatment outweigh the short-term or long-term
117117 physical risks;
118118 (2) whether clear and convincing evidence establishes
119119 that the short-term and long-term psychological benefits of the
120120 proposed medical procedure or treatment outweigh the short-term or
121121 long-term psychological risks;
122122 (3) the extent to which the proposed medical procedure
123123 or treatment would limit the child's future options for:
124124 (A) fertility;
125125 (B) development or construction of
126126 female-typical characteristics;
127127 (C) development or construction of male-typical
128128 characteristics; and
129129 (D) preservation of body characteristics
130130 unaltered by decisions the child did not initiate; and
131131 (4) whether clear and convincing evidence establishes
132132 that any limitation identified under Subdivision (3) is justified
133133 by an urgent need for the proposed medical procedure or treatment.
134134 (f) If the requirements of Sections 266.054(1) and (2) are
135135 satisfied, the court may consider the child's consent to the
136136 proposed medical procedure or treatment related to an intersex
137137 trait as clear and convincing evidence for purposes of the court's
138138 best-interest determination under Subsection (e).
139139 Sec. 266.054. FOSTER CHILD'S CONSENT TO MEDICAL PROCEDURE
140140 OR TREATMENT. Notwithstanding Section 32.003 or 266.004 or other
141141 law, a foster child 12 years of age or older may consent to a medical
142142 procedure or treatment related to an intersex trait if the child:
143143 (1) has been evaluated by a physician and a
144144 psychologist, both of whom have had previous experience treating
145145 patients with intersex traits, and the physician and psychologist
146146 determine the child has the maturity necessary to make decisions
147147 regarding the child's medical care; and
148148 (2) has been provided with the information necessary
149149 to enable the child to provide voluntary and informed consent to the
150150 proposed medical procedure or treatment, including:
151151 (A) the nature of the proposed medical procedure
152152 or treatment, including whether and to what extent the proposed
153153 procedure or treatment is irreversible;
154154 (B) the projected outcome of the proposed medical
155155 procedure or treatment, including whether the benefits of the
156156 procedure or treatment are medical, psychological, or social, and
157157 the strength of the evidence supporting the claims that the
158158 procedure or treatment provides each of those benefits;
159159 (C) the possible risks associated with the
160160 proposed medical procedure or treatment, including, as applicable,
161161 loss of reproductive capacity, loss of sexual function or
162162 sensation, and the child's ultimate gender identity differing from
163163 the sex assigned; and
164164 (D) the alternatives to the proposed medical
165165 procedure or treatment, including delaying the procedure or
166166 treatment.
167167 SECTION 3. This Act takes effect immediately if it receives
168168 a vote of two-thirds of all the members elected to each house, as
169169 provided by Section 39, Article III, Texas Constitution. If this
170170 Act does not receive the vote necessary for immediate effect, this
171171 Act takes effect September 1, 2017.